AyurMaya Capital Management Company, LP

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), AyurMaya Capital Management Company, LP reported 2 stock positions worth $159.7 million. Its top holding was Alumis (ALMS) at 71.2% of the portfolio, followed by Acelyrin (SLRN, 28.8%). Its holdings were unchanged from Q2 2024.

Most Recent 13F
Q2 2026
Location
Portsmouth, NH
CIK
0001975990
Portfolio Value
$159.7M (Q3 2024)
SEC Filing
0001172661-24-005164 ↗ filed Nov 14, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $63.0M Q1 2024 Q2 2024: $182.8M Q2 2024 Q3 2024: $159.7M $159.7M Q3 2024 Q4 2024: $113.0M Q4 2024 Q1 2025: $88.4M Q1 2025 Q2 2025: $45.4M Q2 2025 Q3 2025: $60.4M Q3 2025 Q4 2025: $147.8M Q4 2025 Q1 2026: $333.5M Q1 2026 Q2 2026: $426.0M Q2 2026

Holdings 2 stocks · $159.7M
ALMS Alumis Inc. 71.19% 10,645,965 $113.7M No change
SLRN Acelyrin Inc. 28.81% 9,334,735 $46.0M No change

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$426.0MALMS
Q1 2026 1$333.5MALMS
Q4 2025 1$147.8MALMS
Q3 2025 1$60.4MALMS
Q2 2025 1$45.4MALMS
Q1 2025 2$88.4MALMS, SLRN
Q4 2024 2$113.0MALMS, SLRN
Q3 2024 2$159.7MALMS, SLRN
Q2 2024 2$182.8MALMS, SLRN
Q1 2024 1$63.0MSLRN